Search research articles
Contact Us
Filters
Showing results (21-30 of 2,232) with videos related to
Page
of 224
Sort By:
ESMO Open
|
February 8, 2021
MDM2/4 amplification predicts poor response to immune checkpoint inhibitors: a pan-cancer analysis
Wenfeng Fang, Huaqiang Zhou, Jiayi Shen, et al.
ESMO Open
|
February 8, 2021
BIG BANG study (EPOC1703): multicentre, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy with binimetinib, encorafenib and cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancer
Daisuke Kotani, Hideaki Bando, Hiroya Taniguchi, et al.
ESMO Open
|
January 3, 2022
Impact of the timing of tumor assessments on median progression-free survival in clinical trials in advanced cancer patients
T Samaille, C Moreau Bachelard, E Coquan, et al.
ESMO Open
|
January 13, 2022
ESMO Clinical Practice Guidelines: adapting and adopting new approaches for development, implementation and audit
G Pentheroudakis, G Curigliano, C Zielinski
ESMO Open
|
January 7, 2022
How we treat patients with metastatic HER2-positive breast cancer
G Nader-Marta, D Martins-Branco, E de Azambuja
ESMO Open
|
January 1, 2022
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up
A Lasagna, D Lilleri, F Agustoni, et al.
ESMO Open
|
March 21, 2021
Phase II study of trifluridine/tipiracil plus bevacizumab by RAS mutation status in patients with metastatic colorectal cancer refractory to standard therapies: JFMC51-1702-C7
T Takahashi, K Yamazaki, E Oki, et al.
ESMO Open
|
December 24, 2021
Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities
M Simbolo, G Centonze, G Ali, et al.
ESMO Open
|
December 25, 2021
IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer
O Molinier, B Besse, F Barlesi, et al.
ESMO Open
|
December 25, 2021
Results of a single-arm pilot study of <sup>32</sup>P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy
P J Ross, H S Wasan, D Croagh, et al.
Page
of 224
Search research articles
Search
Showing results (21-30 of 2,232) with videos related to
Sort By:
Page
of 224
ESMO Open
|
February 8, 2021
MDM2/4 amplification predicts poor response to immune checkpoint inhibitors: a pan-cancer analysis
Wenfeng Fang, Huaqiang Zhou, Jiayi Shen, et al.
ESMO Open
|
February 8, 2021
BIG BANG study (EPOC1703): multicentre, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy with binimetinib, encorafenib and cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancer
Daisuke Kotani, Hideaki Bando, Hiroya Taniguchi, et al.
ESMO Open
|
January 3, 2022
Impact of the timing of tumor assessments on median progression-free survival in clinical trials in advanced cancer patients
T Samaille, C Moreau Bachelard, E Coquan, et al.
ESMO Open
|
January 13, 2022
ESMO Clinical Practice Guidelines: adapting and adopting new approaches for development, implementation and audit
G Pentheroudakis, G Curigliano, C Zielinski
ESMO Open
|
January 7, 2022
How we treat patients with metastatic HER2-positive breast cancer
G Nader-Marta, D Martins-Branco, E de Azambuja
ESMO Open
|
January 1, 2022
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up
A Lasagna, D Lilleri, F Agustoni, et al.
ESMO Open
|
March 21, 2021
Phase II study of trifluridine/tipiracil plus bevacizumab by RAS mutation status in patients with metastatic colorectal cancer refractory to standard therapies: JFMC51-1702-C7
T Takahashi, K Yamazaki, E Oki, et al.
ESMO Open
|
December 24, 2021
Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities
M Simbolo, G Centonze, G Ali, et al.
ESMO Open
|
December 25, 2021
IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer
O Molinier, B Besse, F Barlesi, et al.
ESMO Open
|
December 25, 2021
Results of a single-arm pilot study of <sup>32</sup>P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy
P J Ross, H S Wasan, D Croagh, et al.
Page
of 224